Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
RESEARCH TOOLSreports
Olema Pharmaceuticals (OLMA) Stock Price & Analysis
369 Followers
OLMA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.00 - $17.79
Previous Close$11.32
Volume499.22K
Average Volume (3M)812.08K
Market Cap
$632.95M
Enterprise Value$373.56M
Total Cash (Recent Filing)$261.81M
Total Debt (Recent Filing)$2.42M
Price to Earnings (P/E)-5.2
Beta1.99
Next Earnings
May 07, 2024EPS Estimate
-$0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.16
Shares Outstanding55,914,741
10 Day Avg. Volume1,327,462
30 Day Avg. Volume812,082
Standard Deviation0.30
R-Squared0.13
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.49
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-8.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.97
Forecast
1Y Price Target
$25.00Price Target Upside120.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Olema Pharmaceuticals News
PremiumStock Analysis & Ideas
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
OLMA FAQ
What was Olema Pharmaceuticals’s price range in the past 12 months?
Olema Pharmaceuticals lowest stock price was $3.00 and its highest was $17.79 in the past 12 months.
What is Olema Pharmaceuticals’s market cap?
Currently, no data Available
When is Olema Pharmaceuticals’s upcoming earnings report date?
Olema Pharmaceuticals’s upcoming earnings report date is May 07, 2024 which is in 18 days.
How were Olema Pharmaceuticals’s earnings last quarter?
Olema Pharmaceuticals released its earnings results on Mar 11, 2024. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.48 by -$0.01.
Is Olema Pharmaceuticals overvalued?
According to Wall Street analysts Olema Pharmaceuticals’s price is currently Undervalued.
Does Olema Pharmaceuticals pay dividends?
Olema Pharmaceuticals does not currently pay dividends.
What is Olema Pharmaceuticals’s EPS estimate?
Olema Pharmaceuticals’s EPS estimate is -$0.52.
How many shares outstanding does Olema Pharmaceuticals have?
Olema Pharmaceuticals has 55,914,740 shares outstanding.
What happened to Olema Pharmaceuticals’s price movement after its last earnings report?
Olema Pharmaceuticals reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.48. Following the earnings report the stock price went down -6.615%.
Which hedge fund is a major shareholder of Olema Pharmaceuticals?
Among the largest hedge funds holding Olema Pharmaceuticals’s share is Woodline Partners LP. It holds Olema Pharmaceuticals’s shares valued at 11M.
---
Olema Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.00 (120.85% Upside)
$25.00 (120.85% Upside)
Blogger Sentiment
Bullish
OLMA Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 472.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $558.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 13.3%
Last 30 Days ▲ 13.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
222.50%
12-Months-Change
Fundamentals
Return on Equity
-42.82%
Trailing 12-Months
Asset Growth
28.43%
Trailing 12-Months
Company Description
Olema Pharmaceuticals
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.
---
OLMA Stock 12 Months Forecast
Average Price Target
$25.00
▲(120.85% Upside)
Technical Analysis
Arvinas Holding Company
―
Mersana Therapeutics
―
Allogene Therapeutics
―
Kura Oncology
―
Best Analysts Covering OLMA
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+119.07%
reiterated a buy rating last month
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +119.07% per trade.
---